SAMLYN CAPITAL, LLC Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$4.3T
Holdings
128
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (128 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —IMPAX LABORATORIES INC | 568,000 | $7.2B | 0.17% | |
| 102 | CFGCITIZENS FINL GROUP INC | 207,600 | $7.2B | 0.17% | |
| 103 | RDNRADIAN GROUP INC | 392,500 | $7.0B | 0.16% | |
| 104 | COSTCOSTCO WHSL CORP NEW | 41,981 | $7.0B | 0.16% | |
| 105 | SRPTSAREPTA THERAPEUTICS INC | 234,300 | $6.9B | 0.16% | |
| 106 | BF/BBROWN FORMAN CORP | 150,000 | $6.9B | 0.16% | Call |
| 107 | NKENIKE INC | 114,606 | $6.4B | 0.15% | |
| 108 | TXRHTEXAS ROADHOUSE INC | 136,281 | $6.1B | 0.14% | |
| 109 | ALXNALEXION PHARMACEUTICALS INC | 49,300 | $6.0B | 0.14% | |
| 110 | KOCOCA COLA CO | 135,000 | $5.7B | 0.13% | Put |
| 111 | ITCIEURINTRA CELLULAR THERAPIES INC | 338,500 | $5.5B | 0.13% | |
| 112 | BABAALIBABA GROUP HLDG LTD | 47,451 | $5.1B | 0.12% | |
| 113 | ESNTESSENT GROUP LTD | 139,300 | $5.0B | 0.12% | |
| 114 | —DERMIRA INC | 146,000 | $5.0B | 0.12% | |
| 115 | VRTXVERTEX PHARMACEUTICALS INC | 45,112 | $4.9B | 0.11% | |
| 116 | NVROEURNEVRO CORP | 47,191 | $4.4B | 0.10% | |
| 117 | ACADACADIA PHARMACEUTICALS INC | 125,800 | $4.3B | 0.10% | |
| 118 | ANFABERCROMBIE & FITCH CO | 360,089 | $4.3B | 0.10% | |
| 119 | DGDOLLAR GEN CORP NEW | 58,474 | $4.1B | 0.09% | |
| 120 | SG7SAGE THERAPEUTICS INC | 56,700 | $4.0B | 0.09% | |
| 121 | NBIXNEUROCRINE BIOSCIENCES INC | 92,983 | $4.0B | 0.09% | |
| 122 | —BLUEBIRD BIO INC | 43,600 | $4.0B | 0.09% | |
| 123 | —HSN INC | 106,719 | $4.0B | 0.09% | |
| 124 | TSCOTRACTOR SUPPLY CO | 57,116 | $3.9B | 0.09% | |
| 125 | —ALDER BIOPHARMACEUTICALS INC | 181,143 | $3.8B | 0.09% | |
| 126 | DKSDICKS SPORTING GOODS INC | 70,292 | $3.4B | 0.08% | |
| 127 | INCYINCYTE CORP | 22,500 | $3.0B | 0.07% | |
| 128 | —WMIH CORP | 53,420 | $78.0M | 0.00% |
PreviousPage 2 of 2